F9 and hemoglobin measurement: We previously illustrated that CRISPR/Cas9 helped to efficiently integrate the human F9 expression cassette into the ribosomal DNA (rDNA) region of mouse embryonic stem cells, enabling gene therapy for HB based on nonviral vectors [25].